Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
JMIR Research Protocols|January 10, 2023
Correlation Between Serum and Urine Biomarkers and the Intensity of Acute Radiation Cystitis in Patients Treated With Radiation Therapy for Localized Prostate Cancer: Protocol for the Radiotoxicity Bladder Biomarkers (RABBIO) StudyCarole Helissey, Sophie Cavallero, Stanislas Mondot, et al.
Biology|September 14, 2022
Two New Potential Therapeutic Approaches in Radiation Cystitis Derived from Mesenchymal Stem Cells: Extracellular Vesicles and Conditioned MediumCarole Helissey, Nathalie Guitard, Hélène Théry, et al.
Bulletin Du Cancer|December 19, 2024
Optimizing the management of immune-related adverse events and survival in patients with thoracic cancer receiving immunotherapy through artificial intelligence (electronic patient-reported outcomes): The IMPATHI studySerge Amouin, Laurent Brureau, Charles Parnot, et al.
Bulletin Du Cancer|December 10, 2013
Combination of paclitaxel and bevacizumab in heavily pre-treated non-small-cell lung cancer (NSCLC) patients: a case series study on 15 patientsSylvestre Le Moulec, Julien Hadoux, Eric Gontier, et al.
Journal of Geriatric Oncology|September 12, 2017
Are phase I trials safe for older patients?Capucine Baldini, Olivia Le Saux, Carole Helissey, et al.
BMC Cancer|May 24, 2017
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective studyAlison C Johnson, Margarida Matias, Helen Boyle, et al.
JMIR Cancer|December 18, 2021
The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective StudyYasmine Meghiref, Charles Parnot, Claire Duverger, et al.
The French Journal of Urology|June 1, 2024
Multidisciplinary real-world management of metastatic castration-sensitive prostate cancer: A French national study (PROFILE study)Carole Helissey, Denis Maillet, Bérengère Narciso, et al.
Cancer Medicine|August 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancerCedric Pobel, Edouard Auclin, Diego Teyssonneau, et al.
Oncology Letters|November 3, 2025
Gastrointestinal metastasis in prostate cancer and therapeutic implications: A case reportMarie-Anne Audisio, Anh-Tuan Nguyen, Evelyne Peroux, et al.
Pageof 6